|
Name |
(E)-3-(Methylthio)propenoic acid [(3R)-3beta-isopropenyl-4abeta,5beta-dimethyl-2,3,4,4a,5,6,7,8-octahydro-2-oxonaphthalen]-6alpha-yl ester
|
Molecular Formula | C19H26O3S | |
IUPAC Name* |
[(1R,2R,7R,8aR)-1,8a-dimethyl-6-oxo-7-prop-1-en-2-yl-1,2,3,4,7,8-hexahydronaphthalen-2-yl] (E)-3-methylsulfanylprop-2-enoate
|
|
SMILES |
C[C@H]1[C@@H](CCC2=CC(=O)[C@H](C[C@]12C)C(=C)C)OC(=O)/C=C/SC
|
|
InChI |
InChI=1S/C19H26O3S/c1-12(2)15-11-19(4)13(3)17(22-18(21)8-9-23-5)7-6-14(19)10-16(15)20/h8-10,13,15,17H,1,6-7,11H2,2-5H3/b9-8+/t13-,15+,17+,19+/m0/s1
|
|
InChIKey |
OHANKWLYFDFHOJ-GPONIZCZSA-N
|
|
Synonyms |
(E)-3-(Methylthio)propenoic acid [(3R)-3beta-isopropenyl-4abeta,5beta-dimethyl-2,3,4,4a,5,6,7,8-octahydro-2-oxonaphthalen]-6alpha-yl ester
|
|
CAS | NA | |
PubChem CID | 12314127 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 334.5 | ALogp: | 4.1 |
HBD: | 0 | HBA: | 4 |
Rotatable Bonds: | 5 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 68.7 | Aromatic Rings: | 2 |
Heavy Atoms: | 23 | QED Weighted: | 0.419 |
Caco-2 Permeability: | -4.541 | MDCK Permeability: | 0.00001530 |
Pgp-inhibitor: | 0.02 | Pgp-substrate: | 0.28 |
Human Intestinal Absorption (HIA): | 0.007 | 20% Bioavailability (F20%): | 0.003 |
30% Bioavailability (F30%): | 0.008 |
Blood-Brain-Barrier Penetration (BBB): | 0.084 | Plasma Protein Binding (PPB): | 89.52% |
Volume Distribution (VD): | 1.197 | Fu: | 14.91% |
CYP1A2-inhibitor: | 0.465 | CYP1A2-substrate: | 0.606 |
CYP2C19-inhibitor: | 0.939 | CYP2C19-substrate: | 0.841 |
CYP2C9-inhibitor: | 0.893 | CYP2C9-substrate: | 0.894 |
CYP2D6-inhibitor: | 0.892 | CYP2D6-substrate: | 0.311 |
CYP3A4-inhibitor: | 0.901 | CYP3A4-substrate: | 0.698 |
Clearance (CL): | 7.448 | Half-life (T1/2): | 0.6 |
hERG Blockers: | 0.001 | Human Hepatotoxicity (H-HT): | 0.167 |
Drug-inuced Liver Injury (DILI): | 0.517 | AMES Toxicity: | 0.163 |
Rat Oral Acute Toxicity: | 0.353 | Maximum Recommended Daily Dose: | 0.254 |
Skin Sensitization: | 0.955 | Carcinogencity: | 0.565 |
Eye Corrosion: | 0.919 | Eye Irritation: | 0.954 |
Respiratory Toxicity: | 0.878 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001526 | 0.574 | D07BSQ | 0.273 | ||||
ENC004127 | 0.500 | D02CJX | 0.269 | ||||
ENC003665 | 0.437 | D04SFH | 0.262 | ||||
ENC005061 | 0.402 | D0X4RS | 0.259 | ||||
ENC004660 | 0.368 | D00AEQ | 0.254 | ||||
ENC005064 | 0.358 | D0W5LS | 0.252 | ||||
ENC003895 | 0.355 | D0D2TN | 0.250 | ||||
ENC002137 | 0.336 | D0I2SD | 0.250 | ||||
ENC004128 | 0.330 | D0G8BV | 0.248 | ||||
ENC001924 | 0.304 | D08TEJ | 0.246 |